Biobanking Market Size to Reach USD 67.90 Billion in 2030 | Increase in Research Activities for Regenerative Medicines, Stem Cell Therapeutics and Cell and Gene Therapy are Key Factors Driving Industry Demand, According to Emergen Research

USA - English

• USA - English
• USA - English

VANCOUVER, BC, Feb. 7, 2022 /PRNewswire/ -- The global biobanking market size was USD 29.79 Billion in 2020. Increasing need for genetic testing and personalized medicine are key factors driving global market revenue growth. Biobanks play a crucial role in biomedical research. Biobanks not only speed up the process of transfer of scientific knowledge into technical applications, but also give rise to situations, where obtaining such knowledge is dependent mainly on technology.

Drivers: Increased application in clinical and scientific research

Biobanks are an important resource for genomics, proteomics, metabolomic research, molecular epidemiology, translational studies, and therapeutic target creation. Thus, academic and industry researchers are showing increased interest in biobanking. Biobanking is gaining traction in the field of biomedical research. Several biobanks across the globe are assisting in medical research and clinical trials of personalized medicine as they aid in identification of biomarkers and various pharmaceutical treatments.

Get Free Sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/926

Restraints: Issues related to procurement of samples

A key factor limiting growth of the global biobanking market is issues related with procurement of biospecimen samples which is a complex procedure and involves complications and processes to be fulfilled. Moreover, biobanking equipment are expensive and this limits adoption in some developing countries.

Growth Projections

The global biobanking market size is expected to reach USD 67.90 Billion in 2030 and register a revenue CAGR of 8.6% over the forecast period. Increased focus on regenerative medicine for treatment of cancer, diabetes, Alzheimer's Disease, and other rare genetic diseases is driving biobanking market revenue growth. Umbilical cords and stem cells are preserved in biobanks to help in development of regenerative medicines and the trend is gaining traction currently.

COVID-19 Direct Impacts

Biobanking market registered significant growth during the COVID-19 pandemic as researchers stored numerous samples of bronchioalveolar lavage, oropharyngeal/ nasopharyngeal swabs, blood, sputum, urine, and stool of infected patients. The samples were collected and archived for future use to develop diagnostics, therapies, and vaccines. COVID-19 biorepositories in India alone collected over 40,000 samples for researchers to develop vaccines/therapies.

Current Trends and Innovations

Biobanks has entered the Big Data era with advancements in Artificial Intelligence (AI)-driven data analytics, process automation, robotics, and other technological advancements. This has resulted in higher quality biobanking data and contribute to a shift to data driven science. Well processed Big Data allow collaboration of biobanks in different regions and with advanced technology, these data can be handled easily. Storage option on cloud also helps resolve limited local storage capacity issue.

Geographical Outlook

Market in North America accounted for largest revenue share in 2020 due to advancements in drug discovery and increased investment in personalized and regenerative medicine. Increasing prevalence of cancer, cardiovascular, and infectious diseases is boosting growth of the market in the region. Large number of clinical trials related to COVID-19 and increasing usage of stem cell therapies for treatment of various chronic diseases is also driving market growth.

Looking for Discount on Biobanking market report [Click Here]@ https://www.emergenresearch.com/request-discount/926

Strategic Initiatives

In July 2021, BioIVT, which is a U.S.-based provider of research and high-quality biological specimens and value-added services, acquired Tissue Solutions Ltd., which is a virtual biobank in the U.K. The acquisition will add 150 collection sites to BioIVT's network, giving access to high-quality control and disease state biospecimen. It will also help in expanding skin product offerings for in-vitro models.

Some Key Highlights From the Report

• Human tissue segment is expected to register a rapid revenue growth rate during the forecast period owing to large number of biobanks with facilities to store tissues, availability of samples and advanced technology for storage and retrieval of stored tissues. Increased investment in disease specific R&D is expected to propel demand for diseased tissues associated with myeloma, leukemia, lymphoma, prostate and lung, among other for oncology studies.
• Clinical research segment is expected to register a rapid revenue growth rate during the forecast period, attributed to rising demand for bio-samples for drug testing in clinical research. Increase in number of COVID-19 cases across the globe has resulted in high demand for vaccine development. Governments in developing countries are also investing in clinical trials, which is further contributing to revenue growth of this segment.
• Biobank software helps biobanks to manage samples and metadata, automate and streamline workflows, locate stored samples, and remove data silos. Biobank software can be accessed anywhere, anytime and enable biorepositories to scale up and automate operations without having to invest in IT infrastructure.
• Some major companies included in the market report are U.K. Biobank Limited, Medizinische Universitat Graz, Hamilton Company, ASKION, Azenta Life Sciences, Qiagen, Promega Corporation, Integrated Biobank of Luxembourg (IBBL), Isenet Biobanking, and Thermo Fisher Scientific, Inc.

Explore Complete Report Description and Table of Contents of Biobanking Market Report@ https://www.emergenresearch.com/industry-report/biobanking-market

Emergen Research has segmented the global biobanking market on the basis of product & services, sample type, storage type, application, and region:

• Product & Services Outlook (Revenue, USD Billion; 2018–2030)
• Equipment
1. Storage Equipment
2. Sample Transport Equipment
3. Sample Processing Equipment
4. Sample Analysis Equipment
• Consumables
1. Collection Consumables
2. Storage Consumables
3. Processing Consumables
4. Analysis Consumables
• Services
1. Supply Services
2. Processing Services
3. Storage Services
4. Transport Services
• Software
• Sample Type Outlook (Revenue, USD Billion; 2018–2030)
• Biological Fluids
• Human Tissues
• Blood Products
• Nucleic Acids
• Human Waste Products
• Cell Lines
• Storage Type Outlook (Revenue, USD Billion; 2018–2030)
• Automated Storage
• Manual Storage
• Application Outlook (Revenue, USD Billion; 2018–2030)
• Regenerative Medicine
• Life Science Research
• Clinical Research

Buy Your Exclusive Copy@ https://www.emergenresearch.com/select-license/926

• Regional Outlook (Revenue, USD Billion; 2018–2030)
• North America
1. U.S.
2. Canada
3. Mexico
• Europe
1. Germany
2. U.K.
3. France
4. Italy
5. Spain
6. Sweden
7. BENELUX
8. Rest of Europe
• Asia Pacific
1. China
2. India
3. Japan
4. South Korea
5. Rest of APAC
• Latin America
1. Brazil
2. Rest of LATAM
• Middle East & Africa
1. Saudi Arabia
2. UAE
3. South Africa
4. Israel
5. Rest of MEA

Want to Explore Complete Table of Content (TOC) for Biobanking Market[Click Here]@ https://www.emergenresearch.com/industry-report/biobanking-market/toc

Latest Published Reports by Emergen Research in Healthcare And Pharmaceuticals Industry Segment:

Targeted Therapeutics Market, By Therapy (Monoclonal Antibodies, Small Molecule Inhibitors), By Disease Indication, By End-use, and By Region Forecast to 2028.

Dermal Regeneration Template Market By Type (Fortified Type, Fenestrated Type, Single Layer Type), By Application (Massively Burned Patients, Acutely Excised Wounds, Chronic Wounds, Others), By End Use (Hospital, Wound Care, Others) By Region Forecast to 2028.

Telehealth Market, By Type (Tele-Home and Tele-Hospital), By Component, By Deployment Model (Web & Cloud-based and On-premises), By Application, By End-user, and By Region Forecast to 2028.

Augmented Reality and Virtual Reality in Healthcare Market By Technology (Augmented Reality, Virtual Reality), By Component (Hardware, Software, Services), By Application (Surgery, Training & Education), By End-use (Hospitals, Clinics), and By Region Forecast to 2030.

Leadless Pacemaker Systems Market, By Product Type, By Application (Atrial Fibrillation, Sinus Node Dysfunction, Atrioventricular Block and Others), By Technology, By End-use, and By Region Forecast to 2028.

Biodefense Market Size, Share, Trends, By Product Type (COVID-19 Vaccine, Anthrax Vaccine, Others), By Biothreat Detection Device Type, By End-Use, and By Region Forecast to 2028.

Cryotherapy Market By Product (Localized Cryotherapy Devices, Cryosurgery Devices, Cryochambers & Cryosaunas, Gas Cylinders, Others), By Therapy (Icepack Therapy, Cryosurgery, Chamber Therapy), By Application, By End-Use, and By Region Forecast to 2028

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com  
Direct Line: +1 (604) 757-9756
E-mail: [email protected]  
Visit for More Insights: https://www.emergenresearch.com/insights  
Explore Our Custom Intelligence services | Growth Consulting Services 
Read our Press Release on Biobanking @ https://www.emergenresearch.com/press-release/global-biobanking-market

SOURCE Emergen Research